---
category: news
title: "Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635"
excerpt: "Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, announced that its Phase 1b proof-of-concept (POC) study of its lead drug candidate,"
publishedDateTime: 2023-11-29T12:38:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/verge-genomics-will-use-modality-ai-in-its-als-phase-1b-clinical-trial-of-its-lead-drug-candidate-vrg50635-1032858018"
webUrl: "https://markets.businessinsider.com/news/stocks/verge-genomics-will-use-modality-ai-in-its-als-phase-1b-clinical-trial-of-its-lead-drug-candidate-vrg50635-1032858018"
type: article
quality: 31
heat: 31
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Meta AI
  - AI

secured: "u6jPMtYYG1c24riixCrH2paZ96EnWRTvkWaoSt74GuCqdVdDq9EUrCR2INPrAfqNZHPVAfK+LraXXkX0hMpGLraFhbtFQ1RWIOGXk3vj22dtBlPzTYGwXfNT/0+XYeHgPxUWfXZ+UKvCZSWtzXUKfDSi5XNyt9yrPIyFwOlrs3v8dJLWzzdWz28NoXlNcd47JAvBLhfsqjJBcRLfa+ZEQ+7c+4pRoS+QHVR2te2ee3mQRK21+66/yErIcpd8wP7b38dqV/TzD8YyiTpfyyYSzCtI0prD92IHHJPdrGEmoEz/MWn6ZTDmNSZLHKKNrM2HnBwjTURjIxks2+C61eJykbrIkq6o+GmgUnY/2ZuaBh8=;Sq8Noz4rqoTo5R4eM3NJwg=="
---

